• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在没有痴呆症的老年人中,使用抗胆碱能药物与情景记忆衰退有关。

Anticholinergic drug use is associated with episodic memory decline in older adults without dementia.

作者信息

Papenberg Goran, Bäckman Lars, Fratiglioni Laura, Laukka Erika J, Fastbom Johan, Johnell Kristina

机构信息

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institute and Stockholm University, Stockholm, Sweden.

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institute and Stockholm University, Stockholm, Sweden.

出版信息

Neurobiol Aging. 2017 Jul;55:27-32. doi: 10.1016/j.neurobiolaging.2017.03.009. Epub 2017 Mar 16.

DOI:10.1016/j.neurobiolaging.2017.03.009
PMID:28407520
Abstract

Anticholinergic drug use is common in older adults and has been related to increased dementia risk. This suggests that users of these drugs may experience accelerated cognitive decline. So far, however, longitudinal data on this topic are absent and the available evidence is inconclusive with respect to effects on specific cognitive domains due to suboptimal control of confounding variables. We investigated whether anticholinergic medication use is associated with cognitive decline over 6 years in a population-based study of older adults (aged 60-90; n = 1473) without dementia. We found that users (n = 29) declined more on episodic memory over 6 years compared to nonusers (n = 1418). These results were independent of age, sex, education, overall drug intake, physical activity, depression, cardiovascular risk burden, and cardiovascular disease. By contrast, anticholinergic drug use was unrelated to performance in processing speed, semantic memory, short-term memory, verbal fluency, and global cognition (the Mini-Mental-State Examination). Our results suggest that effects of anticholinergics may be particularly detrimental to episodic memory in older adults, which supports the assertion that the cholinergic system plays an important role in episodic memory formation.

摘要

抗胆碱能药物在老年人中使用普遍,且与痴呆风险增加有关。这表明这些药物使用者可能会经历认知能力加速衰退。然而,到目前为止,关于这一主题的纵向数据尚缺,并且由于混杂变量控制欠佳,现有证据在抗胆碱能药物对特定认知领域的影响方面尚无定论。在一项针对无痴呆的老年人群(年龄60 - 90岁;n = 1473)的基于人群的研究中,我们调查了使用抗胆碱能药物是否与6年内的认知衰退有关。我们发现,与未使用者(n = 1418)相比,使用者(n = 29)在6年内的情景记忆衰退更多。这些结果不受年龄、性别、教育程度、总体药物摄入量、身体活动、抑郁、心血管风险负担和心血管疾病的影响。相比之下,抗胆碱能药物的使用与加工速度、语义记忆、短期记忆、语言流畅性和整体认知(简易精神状态检查表)表现无关。我们的结果表明,抗胆碱能药物的影响可能对老年人的情景记忆特别有害,这支持了胆碱能系统在情景记忆形成中起重要作用的观点。

相似文献

1
Anticholinergic drug use is associated with episodic memory decline in older adults without dementia.在没有痴呆症的老年人中,使用抗胆碱能药物与情景记忆衰退有关。
Neurobiol Aging. 2017 Jul;55:27-32. doi: 10.1016/j.neurobiolaging.2017.03.009. Epub 2017 Mar 16.
2
Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.老年男性使用具有抗胆碱能特性药物与短期认知功能衰退之间的关联:一项台湾的回顾性队列研究
Geriatr Gerontol Int. 2017 Apr;17 Suppl 1:57-64. doi: 10.1111/ggi.13032.
3
Anticholinergic medication burden and cognitive function in participants of the ASPREE study.ASPREE 研究参与者的抗胆碱能药物负担与认知功能。
Pharmacotherapy. 2022 Feb;42(2):134-144. doi: 10.1002/phar.2652. Epub 2021 Dec 14.
4
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.老年普通人群中具有抗胆碱能特性的药物、认知功能减退与痴呆:三城市研究
Arch Intern Med. 2009 Jul 27;169(14):1317-24. doi: 10.1001/archinternmed.2009.229.
5
Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.抗胆碱能药物对认知和移动能力的不良影响:一项在年轻老年人和老老年人中进行的横断面研究中的损害临界值。
Drugs Aging. 2020 Apr;37(4):301-310. doi: 10.1007/s40266-019-00743-z.
6
Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.抗胆碱能药物的使用与认知功能有问题的老年人认知表现的风险:一项横断面分析
Drugs Aging. 2016 Nov;33(11):809-818. doi: 10.1007/s40266-016-0400-3.
7
Use of medications with anticholinergic properties and cognitive function in a young-old community sample.使用具有抗胆碱能特性的药物与认知功能在一个老社区样本。
Int J Geriatr Psychiatry. 2009 Jun;24(6):578-84. doi: 10.1002/gps.2157.
8
Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults: a memory clinic cohort study.累积抗胆碱能和镇静药物暴露对老年人认知的影响:记忆诊所队列研究。
Alzheimers Res Ther. 2024 Jul 23;16(1):163. doi: 10.1186/s13195-024-01530-8.
9
Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.抗胆碱能药物对初级保健中老年人群正常认知向轻度认知障碍的转变的影响。
Pharmacotherapy. 2018 May;38(5):511-519. doi: 10.1002/phar.2106. Epub 2018 Apr 25.
10
Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.减少痴呆老年人药物相关抗胆碱能负担的潜在益处:一项前瞻性队列研究。
Geriatr Gerontol Int. 2013 Jul;13(3):694-700. doi: 10.1111/ggi.12000. Epub 2012 Dec 6.

引用本文的文献

1
Development and Validation of a Nomogram to Predict Depression Risk in Patients with Cardiovascular Disease.预测心血管疾病患者抑郁风险的列线图的开发与验证
Healthcare (Basel). 2025 May 29;13(11):1287. doi: 10.3390/healthcare13111287.
2
The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV.处方药对艾滋病毒感染者抑郁症状和神经认知表现的影响。
Clin Infect Dis. 2025 Apr 30;80(4):871-880. doi: 10.1093/cid/ciae518.
3
Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy.
中年和老年人群中的抗胆碱能负担与较低的认知功能相关,但与脑萎缩无关。
Br J Clin Pharmacol. 2023 Jul;89(7):2224-2235. doi: 10.1111/bcp.15698. Epub 2023 Mar 9.
4
Degree of Polypharmacy and Cognitive Function in Older Women with HIV.老年 HIV 女性患者的药物使用种类与认知功能。
AIDS Res Hum Retroviruses. 2022 Jul;38(7):571-579. doi: 10.1089/AID.2021.0231. Epub 2022 Apr 26.
5
Anticholinergic medication burden and cognitive function in participants of the ASPREE study.ASPREE 研究参与者的抗胆碱能药物负担与认知功能。
Pharmacotherapy. 2022 Feb;42(2):134-144. doi: 10.1002/phar.2652. Epub 2021 Dec 14.
6
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.抗胆碱能负担(预后因素)预测无已知认知综合征的老年患者痴呆或认知能力下降。
Cochrane Database Syst Rev. 2021 May 5;5(5):CD013540. doi: 10.1002/14651858.CD013540.pub2.
7
Promoting Successful Cognitive Aging: A Ten-Year Update.促进成功的认知老化:十年更新。
J Alzheimers Dis. 2021;81(3):871-920. doi: 10.3233/JAD-201462.
8
Interaction between Subjective Memory Decline and Depression Symptom Intensity in Older People. Results of the Second Wave of Cognition of Older People, Education, Recreational Activities, Nutrition, Comorbidities, and Functional Capacity Studies (COPERNICUS).老年人主观记忆衰退与抑郁症状强度之间的相互作用。老年人认知、教育、娱乐活动、营养、合并症及功能能力研究(哥白尼研究)第二波的结果
J Clin Med. 2021 Mar 24;10(7):1334. doi: 10.3390/jcm10071334.
9
The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.载脂蛋白 E4 携带者和非携带者在威斯康星州阿尔茨海默病预防研究中的抗胆碱能药物的认知影响。
Neuropsychology. 2021 Feb;35(2):220-231. doi: 10.1037/neu0000713.
10
Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.抗胆碱能药物与新发痴呆、轻度认知障碍和认知衰退:一项荟萃分析
Age Ageing. 2020 Oct 23;49(6):939-947. doi: 10.1093/ageing/afaa090.